Cervical cytological screening and human papillomavirus DNA testing in flanders

被引:8
|
作者
Sahebali, S
Depuydt, CE
Segers, K
Vereecken, AJ
Bogers, JJ
机构
[1] Lab Klin Pathol, Labo RIATOL, B-2000 Antwerp, Belgium
[2] Univ Antwerp, B-2610 Antwerp, Belgium
关键词
liquid-based cytology; cervical cancer; HPV; Belgium;
D O I
10.1179/acb.2003.58.4.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The causal relationship between genital human papillomavirus (HPV) infection and cervical dysplasia/ carcinoma has been recognised for some time. The aim of this study was to document the occurrence and distribution of HPV infection in the five provinces of the Flemish region in Belgium and to correlate the HPV DNA test results with the cytological results on simultaneously performed thin layer preparations of cervical cells. Out of a total screened group of 105107 samples, 1978 samples with cytological abnormalities were tested for HPV DNA using the MY09/MY11 consensus PCR. The mean age of the whole group was 36.9 years. The LSIL group, with a mean age of 33.6 years, was significantly younger than the other groups. There was no significant difference in HPV prevalence among the provinces. In four out of five provinces the HPV prevalence reached 100% in high-grade lesions. There is a significant increase in predominance of high-risk HPV types, with increasing abnormal cytology (17.9% WNL < 51.1% ASCUS < 83.8 % LSIL < 97.2% HSIL). Three peaks of HPV DNA positivity were observed, a first at 22 yrs (82%), a second at 47 yrs (60%) and a third in women older than 65 yrs (52%). These results shed more light on HPV prevalence in Flanders and show that the MY09/MY11 consensus primer based detection system is very suitable for the detection of HPV infections in Flanders.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 50 条
  • [1] Human Papillomavirus DNA Testing for Cervical Cancer Screening
    Belinson, Suzanne E.
    Belinson, Jerome L.
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2010, 14 (04) : 215 - 222
  • [2] Role of human papillomavirus DNA testing in screening for cervical cancer
    不详
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 121 : 110 - 110
  • [3] Expanded cytological referral criteria for colposcopy in cervical screening: Comparison with human papillomavirus testing
    Paraskevaidis, E
    Malamou-Mitsi, V
    Koliopoulos, G
    Pappa, L
    Lolis, E
    Georgiou, I
    Agnantis, NJ
    [J]. GYNECOLOGIC ONCOLOGY, 2001, 82 (02) : 355 - 359
  • [4] HUMAN PAPILLOMAVIRUS TESTING IN CERVICAL SCREENING
    TORNE, A
    PUIGTINTORE, LM
    SANCHEZ, E
    [J]. LANCET, 1995, 346 (8977): : 771 - 772
  • [5] Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs
    Lörincz, AT
    Richart, RM
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2003, 127 (08) : 959 - 968
  • [6] HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING
    SUN, XW
    KOULOS, JP
    FELIX, JC
    FERENCZY, A
    RICHART, RM
    PATH, TW
    WRIGHT, TC
    [J]. LANCET, 1995, 346 (8975): : 636 - 636
  • [7] Testing for Human Papillomavirus in Cervical Cancer Screening
    Ha Thanh Nishino
    Tambouret, Rosemary H.
    Wilbur, David C.
    [J]. CANCER CYTOPATHOLOGY, 2011, 119 (04) : 219 - 227
  • [8] Human papillomavirus testing in cervical cancer screening
    S Franceschi
    C Mahé
    [J]. British Journal of Cancer, 2005, 92 : 1591 - 1592
  • [9] Cervical screening: primary human papillomavirus testing
    Cruickshank, M. E.
    Cubie, H. A.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (06) : 650 - 652
  • [10] Human papillomavirus testing in cervical cancer screening
    Franceschi, S
    Mahé, C
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (09) : 1591 - 1592